Literature DB >> 11101630

Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals.

M Anlauf1, E Weihe, W Hartschuh, G Hamscher, G E Feurle.   

Abstract

Xenin is a 25-amino-acid peptide extractable from mammalian tissue. This peptide is biologically active. It stimulates exocrine pancreatic secretion and intestinal motility and inhibits gastric secretion of acid and food intake. Xenin circulates in the human plasma after meals. In this study, the cellular origin of xenin in the gastro-entero-pancreatic system of humans, Rhesus monkeys, and dogs was investigated by immunohistochemistry and immunoelectron microscopy. Sequence-specific antibodies against xenin detected specific endocrine cells in the duodenal and jejunal mucosa of all three species. These xenin-immunoreactive cells were distinct from enterochromaffin, somatostatin, motilin, cholecystokinin, neurotensin, and secretin cells, and comprised 8.8% of the chromogranin A-positive cells in the dog duodenum and 4.6% of the chromogranin A-positive cells in human duodenum. In all three species, co-localization of xenin was found with a subpopulation of gastric inhibitory polypeptide (GIP)-immunoreactive cells. Immunoelectron microscopy in the canine duodenal mucosa demonstrated accumulation of gold particles in round, homogeneous, and osmiophilic secretory granules with a closely adhering membrane of 187 +/- 19 nm diameter (mean +/- SEM). This cell type was found to be identical to the previously described canine GIP cell. Immunocytochemical expression of the peptide xenin in a subpopulation of chromogranin A-positive cells as well as the localization of xenin immunoreactivity in ultrastructurally characterized secretory granules permitted the identification of a novel endocrine cell type as the cellular source of circulating xenin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101630     DOI: 10.1177/002215540004801205

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  23 in total

1.  Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.

Authors:  Burton M Wice; Songyan Wang; Dan L Crimmins; Kelly A Diggs-Andrews; Matthew C Althage; Eric L Ford; Hung Tran; Matthew Ohlendorf; Terry A Griest; Qiuling Wang; Simon J Fisher; Jack H Ladenson; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

Review 2.  Luminal chemosensing in the gastroduodenal mucosa.

Authors:  Izumi Kaji; Jonathan D Kaunitz
Journal:  Curr Opin Gastroenterol       Date:  2017-11       Impact factor: 3.287

3.  Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.

Authors:  Sara Chowdhury; Dominic N Reeds; Dan L Crimmins; Bruce W Patterson; Erin Laciny; Songyan Wang; Hung D Tran; Terry A Griest; David A Rometo; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Kenneth S Polonsky; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

4.  Xenin Augments Duodenal Anion Secretion via Activation of Afferent Neural Pathways.

Authors:  Izumi Kaji; Yasutada Akiba; Ikuo Kato; Koji Maruta; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  J Pharmacol Exp Ther       Date:  2017-01-23       Impact factor: 4.030

5.  Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet.

Authors:  Matthew C Althage; Eric L Ford; Songyan Wang; Patrick Tso; Kenneth S Polonsky; Burton M Wice
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

6.  Evaluation of serum xenin and ghrelin levels and their relationship with nonalcoholic fatty liver disease and insulin resistance in obese adolescents.

Authors:  N Arslan; O Sayin; Y Tokgoz
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

7.  Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.

Authors:  Karin Sterl; Songyan Wang; Lauren Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Peptides       Date:  2016-06-07       Impact factor: 3.750

8.  Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.

Authors:  Sheng Zhang; Krzysztof Hyrc; Songyan Wang; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

9.  The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Regul Pept       Date:  2013-10-29

10.  Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice.

Authors:  Sam G Galvin; Pierre Larraufie; Richard G Kay; Haidee Pitt; Elise Bernard; Anne K McGavigan; Helen Brant; John Hood; Laura Sheldrake; Shannon Conder; Dawn Atherton-Kemp; Van B Lu; Elisabeth A A O'Flaherty; Geoffrey P Roberts; Carina Ämmälä; Lutz Jermutus; David Baker; Fiona M Gribble; Frank Reimann
Journal:  Peptides       Date:  2021-03-17       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.